Taparra, K., Felix, C., Parmisano, S., Wilhalme, H., Nabong, R., Lira, S., Rettig, M., Reiter, R. E., Singer, A. E., Weidhaas, J. B., Czernin, J., Allen-Auerbach, M. S., Valle, L. F., Steinberg, M. L., Calais, J., Kishan, A. U. (2026). Alpha-emitting radionuclide or beta-emitting radionuclide combined with metastasis-directed stereotactic body radiotherapy for oligorecurrent prostate adenocarcinoma (ANDROMEDA): A phase II trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.tps3175